Koji Chono

499 total citations
16 papers, 409 citations indexed

About

Koji Chono is a scholar working on Epidemiology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Koji Chono has authored 16 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 5 papers in Genetics and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Koji Chono's work include Herpesvirus Infections and Treatments (9 papers), Cytomegalovirus and herpesvirus research (7 papers) and Virus-based gene therapy research (5 papers). Koji Chono is often cited by papers focused on Herpesvirus Infections and Treatments (9 papers), Cytomegalovirus and herpesvirus research (7 papers) and Virus-based gene therapy research (5 papers). Koji Chono collaborates with scholars based in Japan and United States. Koji Chono's co-authors include Hiroshi Suzuki, Kiyomitsu Katsumata, Toru Kontani, Etsuro Ito, Kimiyasu Shiraki, Tomoyuki Yokota, Katsuhiro Konno, Yusuke Shimizu, Yutaka Fujito and Akiko Wagatsuma and has published in prestigious journals such as Brain Research, Antimicrobial Agents and Chemotherapy and Molecules.

In The Last Decade

Koji Chono

16 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Koji Chono Japan 12 243 73 66 62 57 16 409
Yuan‐Chuan Chen United States 13 196 0.8× 66 0.9× 50 0.8× 36 0.6× 241 4.2× 40 565
Chengjun Mo China 17 305 1.3× 42 0.6× 73 1.1× 27 0.4× 213 3.7× 27 646
Bhaswati Bandyopadhyay India 13 203 0.8× 273 3.7× 53 0.8× 43 0.7× 215 3.8× 26 674
María C. López United States 12 81 0.3× 93 1.3× 54 0.8× 55 0.9× 170 3.0× 36 555
W. Ponti Italy 13 80 0.3× 54 0.7× 54 0.8× 19 0.3× 142 2.5× 43 458
Elena Cardenal‐Muñoz Spain 15 181 0.7× 103 1.4× 68 1.0× 35 0.6× 207 3.6× 29 707
Joshua D. Yoder United States 12 107 0.4× 212 2.9× 94 1.4× 19 0.3× 144 2.5× 25 513
B.A. Heinz United States 12 196 0.8× 193 2.6× 44 0.7× 76 1.2× 300 5.3× 16 715
Eric M. Mishkin United States 13 184 0.8× 25 0.3× 44 0.7× 45 0.7× 51 0.9× 21 459
Sushmita Singh India 8 164 0.7× 52 0.7× 33 0.5× 35 0.6× 118 2.1× 16 357

Countries citing papers authored by Koji Chono

Since Specialization
Citations

This map shows the geographic impact of Koji Chono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koji Chono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koji Chono more than expected).

Fields of papers citing papers by Koji Chono

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koji Chono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koji Chono. The network helps show where Koji Chono may publish in the future.

Co-authorship network of co-authors of Koji Chono

This figure shows the co-authorship network connecting the top 25 collaborators of Koji Chono. A scholar is included among the top collaborators of Koji Chono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koji Chono. Koji Chono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Yamaguchi, Tetsuo, et al.. (2020). Inhibitory effect of fidaxomicin on biofilm formation in Clostridioides difficile. Journal of Infection and Chemotherapy. 26(7). 685–692. 14 indexed citations
2.
Yamaguchi, Tetsuo, et al.. (2020). The gut microbiome diversity of Clostridioides difficile-inoculated mice treated with vancomycin and fidaxomicin. Journal of Infection and Chemotherapy. 26(5). 483–491. 21 indexed citations
3.
Katsumata, Kiyomitsu, Koji Chono, & Hiroshi Suzuki. (2018). Antiviral efficacy of the helicase-primase inhibitor amenamevir in murine models of severe herpesvirus infection. Biochemical Pharmacology. 158. 201–206. 11 indexed citations
4.
Katashima, Masataka, Atsunori Kaibara, Koji Chono, et al.. (2016). Integrative pharmacokinetic–pharmacodynamic modeling and simulation of amenamevir (ASP2151) for treatment of recurrent genital herpes. Drug Metabolism and Pharmacokinetics. 31(4). 323–332. 2 indexed citations
5.
Chono, Koji, Kiyomitsu Katsumata, Hiroshi Suzuki, & Kimiyasu Shiraki. (2012). Synergistic activity of amenamevir (ASP2151) with nucleoside analogs against herpes simplex virus types 1 and 2 and varicella-zoster virus. Antiviral Research. 97(2). 154–160. 30 indexed citations
6.
Chono, Koji, Kiyomitsu Katsumata, Toru Kontani, Kimiyasu Shiraki, & Hiroshi Suzuki. (2012). Characterization of virus strains resistant to the herpes virus helicase–primase inhibitor ASP2151 (Amenamevir). Biochemical Pharmacology. 84(4). 459–467. 27 indexed citations
7.
Katsumata, Kiyomitsu, Adriana Weinberg, Koji Chono, et al.. (2012). Susceptibility of Herpes Simplex Virus Isolated from Genital Herpes Lesions to ASP2151, a Novel Helicase-Primase Inhibitor. Antimicrobial Agents and Chemotherapy. 56(7). 3587–3591. 14 indexed citations
8.
Katsumata, Kiyomitsu, Koji Chono, Kota Kato, et al.. (2012). Pharmacokinetics and Pharmacodynamics of ASP2151, a Helicase-Primase Inhibitor, in a Murine Model of Herpes Simplex Virus Infection. Antimicrobial Agents and Chemotherapy. 57(3). 1339–1346. 24 indexed citations
9.
Chono, Koji, Tohru Daikoku, Masaya Takemoto, et al.. (2011). Efficacy of ASP2151, a helicase–primase inhibitor, against thymidine kinase-deficient herpes simplex virus type 2 infection in vitro and in vivo. Antiviral Research. 93(2). 301–304. 18 indexed citations
10.
Katsumata, Kiyomitsu, Koji Chono, Kenji Sudo, et al.. (2011). Effect of ASP2151, a Herpesvirus Helicase-Primase Inhibitor, in a Guinea Pig Model of Genital Herpes. Molecules. 16(9). 7210–7223. 28 indexed citations
11.
Chono, Koji, Kiyomitsu Katsumata, Toru Kontani, et al.. (2010). ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2. Journal of Antimicrobial Chemotherapy. 65(8). 1733–1741. 123 indexed citations
12.
Funatsu, Toshiyuki, et al.. (2006). Mucosal acid causes gastric mucosal microcirculatory disturbance in nonsteroidal anti-inflammatory drug-treated rats. European Journal of Pharmacology. 554(1). 53–59. 23 indexed citations
13.
Wagatsuma, Akiko, et al.. (2004). The early snail acquires the learning. Comparison of scores for conditioned taste aversion between morning and afternoon. Acta Biologica Hungarica. 55(1-4). 149–155. 43 indexed citations
14.
Chono, Koji, et al.. (2004). Initiation of functional synapses is associated with AMPA receptor expression. Neuroscience Research Communications. 35(1). 24–31. 1 indexed citations
15.
Chono, Koji, et al.. (2003). A cell model study of calcium influx mechanism regulated by calcium-dependent potassium channels in Purkinje cell dendrites. Journal of Neuroscience Methods. 129(2). 115–127. 6 indexed citations
16.
Chono, Koji, Yutaka Fujito, & Etsuro Ito. (2002). Non-ocular dermal photoreception in the pond snail Lymnaea stagnalis. Brain Research. 951(1). 107–112. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026